egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 6, 2024--
Stay updated with breaking news from Trilogy System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 6, 2024--
The global Single Dose Radiotherapy Services Market is estimated to attain a valuation of US$ 7.88 billion in 2023 and is expected to reach US$ 16 billion by 2033. The market is expected to rise at a CAGR of 7.3% throughout the forecast period.The market’s expansion is propelled by several factors, including the inc...
FinancialContent fully hosted finance channel
IRVINE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve...
JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace